11 |
Analysis of chlamydial and host proteins associated with infection /Chu, Hencelyn G. January 1900 (has links)
Thesis (Ph. D.)--Oregon State University, 2007. / Printout. Includes bibliographical references. Also available on the World Wide Web.
|
12 |
The knowledge, attitudes and behaviour of young Māori women in relation to sexual health a descriptive qualitative study : a thesis submitted to Auckland University of Technology in partial fulfilment of the requirements for the degree of Master of Health Science, 2008 /Waetford, Cathrine Huhana. January 2008 (has links)
Thesis (MHSc--Health Science) -- AUT University, 2008. / Includes bibliographical references. Also held in print (ix, 144 leaves ; 30 cm.) in the Archive at the City Campus (T 613.954 WAE)
|
13 |
Animal models of Chlamydia pneumoniae and atherosclerosis : dissemination to and persistence in atheromatous lesions /Moazed, Teresa Clark. January 1996 (has links)
Thesis (Ph. D.)--University of Washington, 1996. / Vita. Includes bibliographical references (leaves [83]-96).
|
14 |
Prévalence du VIH et des infections génitales à gonocoque et à chlamydia et les facteurs associés chez les travailleuses du sexe au Bénin dans le cadre de l'enquête de surveillance de seconde génération /Ahoyo, Arsène Bienvenu. January 2004 (has links)
Thèse (M.Sc.)--Université Laval, 2004. / Bibliogr.: f. 62-76. Publié aussi en version électronique.
|
15 |
Serological studies on <em>Chlamydia pneumoniae</em> infectionsPaldanius, M. (Mika) 21 March 2007 (has links)
Abstract
Chlamydia pneumoniae is a common, widespread pathogen that causes acute and chronic infections. Serological diagnosis of C. pneumoniae infection is primarily based on the microimmunofluorescence (MIF) method, but only a fourfold IgG antibody increase between paired sera and the presence of IgM antibodies have generally been accepted as markers of acute infection. At the present, no commonly accepted, reliable serological or other methods for the diagnosis of chronic C. pneumoniae infection exist.
We evaluated C. pneumoniae specific serological tests in different populations, followed the kinetics of C. pneumoniae antibodies in multiple sera obtained from the same individuals, compared anti-human IgA FITC conjugates in MIF test and evaluated C. pneumoniae specific antibody tests before and after coronary events in case-control pairs matched for the time point of serum sampling, place of residence, and treatment.
We showed that reinfection or reactivation is needed for the persistence of elevated IgG and IgA antibody levels. In chronic infections and upon reactivation, chronic processes may be better diagnosable based on IgA persistence than IgG levels because of the rapid disappearance of IgA levels after seroconversions. The cycle of reinfection and reactivation seems to be faster than previously thought in crowded conditions, such as in military service, since we recorded several antibody changes between the arrival and departure sera of military recruits during 6-month service. The presence of antibodies does not provide protection from reinfection.
Commercial anti-human IgA conjugates act differently in MIF tests, and there is marked variation in their ability to detect IgA antibodies. The EIA test used here overestimated the prevalence and persistence of IgA antibodies when compared to MIF. The best compability between MIF and EIA antibody levels was seen in the participants with high titers.
Only high IgA MIF titers to C. pneumoniae at the baseline predicted future coronary events. In the present study, seroconversions both in the participants who developed a coronary event and in the controls were detected by MIF and EIA, but mostly in different persons. Seroconversion suggesting reinfection or reactivation of persistent infection may have a role in accelerating chronic processes, because the participants with MIF seroconversion between consecutive sera had a slightly higher risk for coronary events than the controls. EIA seroconversions were more common in the controls than in the cases before the coronary event. The difference in the kinetics of EIA and MIF antibodies warrants future research and supports the use of the MIF method as a golden standard in the measurement of C. pneumoniae IgG and IgA antibody levels and seroconversions.
In their diagnostic practice, laboratories should use, compare, and validate more C. pneumoniae IgA antibody tests in addition to IgG tests. Unspecific findings in C. pneumoniae EIA tests require re-estimation and a new way to interpret the results. Chlamydia experts should speak for MIF and rethink the meaning of IgA antibodies and recommendations in the diagnosis of C. pneumoniae infections.
|
16 |
Urethritis and cervicitis with special reference to Chlamydia trachomatis and Mycoplasma genitalium : diagnostic and epidemiological aspects /Falk, Lars, January 2004 (has links) (PDF)
Diss. (sammanfattning) Linköping : Univ., 2004. / Härtill 5 uppsatser.
|
17 |
Genetic variation of chlamydial Inc proteinsViratyosin, Wasna 06 June 2002 (has links)
Genomic analysis is a new approach for the characterization and
investigation of novel genes, gene clusters, the function of uncharacterized
proteins, and genetic diversity in microorganisms. These approaches are important
for the study of chlamydiae, a system in which several genomes have been
sequenced but in which techniques for genetic manipulation are not available. The
objective of this thesis is to combine computer-based analysis of chiamydial
inclusion membrane proteins (Incs) with cellular and molecular biological analysis
of the bacteria. Three different experimental lines of investigation were examined,
focusing on Incs of C. trachomatis and C. pneumoniae.
Chlamydiae are obligate intracellular bacteria that develop within a nonacidified
membrane bound vacuole termed an inclusion. Putative Inc proteins of C.
trachomatis and C. pneumoniae were identified from genomic analysis and a
unique structural motif. Selected putative Inc proteins are shown to localize to the
inclusion membrane.
Chiamydia trachomatis variants with unusual multiple-lobed, nonfusogenic,
inclusion were identified from a large scale serotyping study.
Fluorescence microscopy showed that IncA, a chiamydial protein localized to the
inclusion membrane, was undetectable on non-fusogenic inclusions of these
variants. Sequence analysis of incA from non-fusogenic variant isolates revealed a
defective incA in most of the variants. Some variants lack not only IncA on the
inclusion membrane but also CT223p, an additional Inc protein. However, no
correlation between the absence of CT223p and distinctive inclusion phenotype
was identified. Nucleotide sequence analysis revealed sequence variations of C.
trachomatis incA and CT223 in some variant and wild type isolates.
Comparative analyses of the three recently published C. pneumoniae
genomes have led to the identification of a novel gene cluster named the CPn1O54
gene family. Each member of this family encodes a polypeptide with a hydrophobic
domain characteristic of proteins localized to the inclusion membrane. These
studies provided evidence that gene variation might occur within this single
collection of paralogous genes. Collectively, the variability within this gene family
may modulate either phase or antigenic variation, and subsequent physiologic
diversity, within a C. pneumoniae population.
These studies demonstrate the genetic diversity of Inc proteins and
candidate Inc proteins, within and among the different chiamydial species. This
work sets the stage for further investigations of the structure and function of this set
of proteins that are likely critical to chlamydial intracellular growth. / Graduation date: 2003
|
18 |
Interferons in immunity to chlamydia pneumoniae/Rothfuchs, Antonio Carlos Gigliotti (Tony), January 2004 (has links)
Diss. (sammanfattning) Stockholm : Karol inst., 2004. / Härtill 6 uppsatser.
|
19 |
Osteoarthritis in temporomandibular joint : internal derangement /Paegle, Diana, January 2004 (has links)
Diss. (sammanfattning) Stockholm : Karol inst., 2004. / Härtill 4 uppsatser.
|
20 |
DNA vaccines and bacterial DNA in immunity /Bandholtz, Lisa Charlotta, January 2002 (has links)
Diss. (sammanfattning) Stockholm : Karol. Inst., 2002. / Härtill 4 uppsatser.
|
Page generated in 0.1029 seconds